SCHEMBL8189652

SCHEMBL8189652

CCc1c(Oc2cc(C)cc(C)c2)[nH]c(=O)n(Cc2ccccc2)c1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
ALDH1A1 P00352 5/20 0.45
P2RX3 P56373 1/20 0.42
HPGD P15428 6/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP3A4 P08684 1/20 0.39
C5AR1 P21730 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RGS12 O14924 1/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
TLR7 Q9NYK1 1/20 0.38
PSMD14 O00487 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
TYMS P04818 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7847258 0.91 ALDH1A1 (0.34) KDM4EALDH1A1P2RX3HPGDSMN1; SMN2
SCHEMBL7836586 0.88 HSD17B10 (0.51) KDM4EALDH1A1CYP3A4MEN1KMT2A
SCHEMBL7847304 0.87 GRIN1 (0.44) CYP3A4MEN1KMT2A
SCHEMBL7837064 0.86 HSD17B10 (0.39) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL7847762 0.86 TYMS (0.38) KDM4EALDH1A1P2RX3MEN1KMT2A
SCHEMBL7844403 0.86 GRIN1 (0.37) KDM4EALDH1A1P2RX3MEN1KMT2A
SCHEMBL7847016 0.86 TYMS (0.46) KDM4EALDH1A1P2RX3MEN1KMT2A
SCHEMBL7845923 0.83 DDR1 (0.35) KDM4ESMN1; SMN2MAPTTSHRHTT
SCHEMBL7849134 0.83 LMNA (0.40) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7848747 0.83 GRIN1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000061563-A1 ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2000-10-19 WO disclosed